Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23


Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.

Indian Polycap Study (TIPS), Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, Sigamani A, Mohan V, Gupta R, Thomas N.

Lancet. 2009 Apr 18;373(9672):1341-51. doi: 10.1016/S0140-6736(09)60611-5. Epub 2009 Mar 30.


C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.

Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR.

Circulation. 2008 Nov 25;118(22):2243-51, 4p following 2251. doi: 10.1161/CIRCULATIONAHA.108.814251. Epub 2008 Nov 9.


Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P.

BMJ. 2008 Jun 28;336(7659):1475-82. doi: 10.1136/bmj.39609.449676.25. Epub 2008 Jun 23.


General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB.

Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.


Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R.

Lancet. 2007 Dec 1;370(9602):1829-39. Review. Erratum in: Lancet. 2008 Jul 26;372(9635):292.


Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ.

Lancet. 2006 May 27;367(9524):1747-57.


Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review.

Brindle P, Beswick A, Fahey T, Ebrahim S.

Heart. 2006 Dec;92(12):1752-9. Epub 2006 Apr 18. Review.


The efficacy of combining several risk factors as a screening test.

Wald NJ, Morris JK, Rish S.

J Med Screen. 2005;12(4):197-201.


JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association.

Heart. 2005 Dec;91 Suppl 5:v1-52. No abstract available.


Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators.

Lancet. 2005 Oct 8;366(9493):1267-78. Epub 2005 Sep 27. Erratum in: Lancet. 2005 Oct 15-21;366(9494):1358. Lancet. 2008 Jun 21;371(9630):2084.


Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study.

Getz L, Sigurdsson JA, Hetlevik I, Kirkengen AL, Romundstad S, Holmen J.

BMJ. 2005 Sep 10;331(7516):551. Epub 2005 Aug 15.


Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study.

Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, Ebrahim S.

BMJ. 2003 Nov 29;327(7426):1267.


Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.

Law M, Wald N, Morris J.

Health Technol Assess. 2003;7(31):1-94. Review.


A strategy to reduce cardiovascular disease by more than 80%.

Wald NJ, Law MR.

BMJ. 2003 Jun 28;326(7404):1419. Erratum in: BMJ. 2006 Sep;60(9):823. BMJ. 2003 Sep 13;327(7415):586.


Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration.

Lancet. 2002 Dec 14;360(9349):1903-13. Erratum in: Lancet. 2003 Mar 22;361(9362):1060.


When can a risk factor be used as a worthwhile screening test?

Wald NJ, Hackshaw AK, Frost CD.

BMJ. 1999 Dec 11;319(7224):1562-5. Review. No abstract available.

Supplemental Content

Support Center